S. Pilling

Clinical Psychology · 2002–2017

A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom S. Pilling trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Karina Wahl

Who trusts S. Pilling overall

  1. David M. Clark
  2. Robin L. Carhart-Harris

Papers from S. Pilling's perspective

Ordered by how strongly the researchers S. Pilling trusts endorse each paper. Same corpus, a different order for every researcher.

  1. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. (Journal of Consulting and Clinical Psychology)
  2. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. (New England Journal of Medicine)
  3. A comparison of narrative exposure therapy, supportive counseling, and psychoeducation for treating posttraumatic stress disorder in an african refugee settlement. (Journal of Consulting and Clinical Psychology)
  4. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. (Journal of Consulting and Clinical Psychology)
  5. The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. (Schizophrenia bulletin)
  6. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. (Archives of General Psychiatry)
  7. A controlled comparison of eye movement desensitization and reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder
  8. Human Hallucinogen Research: Guidelines for Safety (Journal of Psychopharmacology)
  9. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Proceedings of the National Academy of Sciences of the United States of America)
  10. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. (Lancet psychiatry)

Their papers